Calcitriol in the treatment of postmenopausal osteoporosis.

[1]  C. Christiansen,et al.  Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study. , 1987, The New England journal of medicine.

[2]  R. Recker,et al.  Estimation of true calcium absorption. , 1985, Annals of internal medicine.

[3]  B. Riggs,et al.  Effect of long term treatment with calcitriol on calcium absorption and mineral metabolism in postmenopausal osteoporosis. , 1985, The Journal of clinical endocrinology and metabolism.

[4]  J. Aloia,et al.  Risk factors for postmenopausal osteoporosis. , 1985, The American journal of medicine.

[5]  M. Horowitz,et al.  1,25-Dihydroxycalciferol and calcium therapy in osteoporosis with calcium malabsorption. Dose response relationship of calcium absorption and indices of bone turnover. , 1985, Mineral and electrolyte metabolism.

[6]  J. Lian,et al.  Urinary γ-Carboxyglutamic Acid and Serum Osteocalcin as Bone Markers: Studies in Osteoporosis and Paget’s Disease , 1983 .

[7]  R. Demuth,et al.  Presence of osteocalcin and related higher molecular weight 4-carboxyglutamic acid-containing proteins in developing bone. , 1983, The Journal of biological chemistry.

[8]  C. Christiansen,et al.  TREATMENT OF POST MENOPAUSAL OSTEOPOROSIS. A CONTROLLED THERAPEUTIC TRIAL COMPARING OESTROGEN/GESTAGEN, 1,25‐DIHYDROXY‐VITAMIN D3 AND CALCIUM , 1982, Clinical endocrinology.

[9]  H. DeLuca,et al.  1,25-Dihydroxyvitamin D3: short- and long-term effects on bone and calcium metabolism in patients with postmenopausal osteoporosis. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[10]  E. Agner,et al.  Serum 1,25-Dihydroxyvitamin D in Normal Subjects and in Patients with Postmenopausal Osteopenia. Influence of Age, Renal Function and Oestrogen Therapy , 1982, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[11]  W. O'Fallon,et al.  Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy. , 1982, The New England journal of medicine.

[12]  J. Aloia,et al.  Rate of bone loss in postmenopausal and osteoporotic women. , 1982, The American journal of physiology.

[13]  J. Adams,et al.  Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients. , 1981, The New England journal of medicine.

[14]  S. Cohn,et al.  Non-Invasive Measurements of Bone Mass and Their Clinical Application , 1981 .

[15]  H. DeLuca,et al.  Serum 1,25-dihydroxyvitamin D levels in normal children and in vitamin D disorders. , 1980, American journal of diseases of children.

[16]  H. DeLuca,et al.  Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium. , 1979, The Journal of clinical investigation.

[17]  M. Harasawa,et al.  Endocrine factors in senile osteoporosis. , 1979, Endocrinologia japonica.

[18]  R. Kumar,et al.  Elevated 1,25-dihydroxyvitamin D plasma levels in normal human pregnancy and lactation. , 1979, The Journal of clinical investigation.

[19]  M. Madsen.  Vertebral and peripheral bone mineral content by photon absorptiometry. , 1977, Investigative radiology.

[20]  H. DeLuca,et al.  A sensitive, precise, and convenient method for determination of 1,25-dihydroxyvitamin D in human plasma. , 1976, Archives of biochemistry and biophysics.

[21]  P. Kelly,et al.  Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis. , 1972, The Journal of clinical investigation.

[22]  J A Sorenson,et al.  Precision and accuracy of bone mineral determination by direct photon absorptiometry. , 1968, Investigative radiology.

[23]  S. Udenfriend,et al.  A specific method for the analysis of hydroxyproline in tissues and urine. , 1960, Analytical biochemistry.

[24]  C. H. Fiske,et al.  THE COLORIMETRIC DETERMINATION OF PHOSPHORUS , 1925 .